Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Helyezés a részvények között
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Részvényárfolyam
$3.40
Piaci kapitalizáció
$9.07B
Változás (1 nap)
-1.61%
Változás (1 év)
-16.08%
Ország
CN
Kereskedés Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Kategória
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) P/S aránya
P/S arány ekkor: 2026 TTM: 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi árbevétel aránya (P/S, TTM) 0. 2026 végén ez az arány 0 volt.
P/S arány története a(z) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. esetén 2001 és 2026 között
P/S arány az év végén
| Év | P/S arány | Változtassa meg |
|---|---|---|
| 2025 | 1.69 | 4.80% |
| 2024 | 1.61 | 0.10% |
| 2023 | 1.61 | -22.99% |
| 2022 | 2.09 | -34.98% |
| 2021 | 3.22 | -29.58% |
| 2020 | 4.57 | 91.44% |
| 2019 | 2.38 | 9.32% |
| 2018 | 2.18 | -63.06% |
| 2017 | 5.91 | 61.09% |
| 2016 | 3.67 | -14.40% |
| 2015 | 4.28 | 6.40% |
| 2014 | 4.03 | -7.88% |
| 2013 | 4.37 | 57.04% |
| 2012 | 2.78 | 10.47% |
| 2011 | 2.52 | -54.62% |
| 2010 | 5.55 | -11.49% |
| 2009 | 6.27 | 80.89% |
| 2008 | 3.47 | -32.97% |
| 2007 | 5.17 | 295.14% |
| 2006 | 1.31 | -8.44% |
| 2005 | 1.43 | -21.64% |
| 2004 | 1.82 | -11.63% |
| 2003 | 2.06 | -48.23% |
| 2002 | 3.99 | -43.85% |
| 2001 | 7.10 | 0.00% |
P/S arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/S arány | P/S arány különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | - |
IN
|
